Grown Rogue International (GRUSF) Interest Coverage Ratio (2011 - 2026)
Grown Rogue International (GRUSF) posted quarterly Interest Coverage Ratio of 0.13 for Q1 2026, down 97.84% year-over-year from 5.99 in Q1 2025, and down 96.38% quarter-over-quarter from 3.58 in Q4 2025.
Grown Rogue International (GRUSF) Interest Coverage Ratio (2011 - 2026) Analysis & Trends
Grown Rogue International's Interest Coverage Ratio history runs 15 years deep, the most recent figure standing at 0.13 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio fell 97.84% year-over-year to 0.13; the TTM figure through Mar 2026 stood at 1135267561156.08 (down 7.2267290720454386e+19% YoY), while the FY2025 annual figure was 0.32, down 2540.44% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 0.13, down from 3.58 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 5549817844267.98 in Q2 2025, with the low at 10.34 in Q1 2024.
- The 5-year median for Interest Coverage Ratio is 2.93 (2025), against an average of 426909064940.95.
- Peak annual rise in Interest Coverage Ratio reached 346449238728738.75% in 2025, while the deepest fall reached 41580904.85% in 2025.
- Grown Rogue International's Interest Coverage Ratio stood at 4.24 in 2022, then plunged by 43.07% to 6.07 in 2023, then surged by 100.0% to 0.0 in 2024, then soared by 50856597.92% to 3.58 in 2025, then plunged by 96.38% to 0.13 in 2026.
- Business Quant data shows GRUSF's Interest Coverage Ratio at 0.13 in Q1 2026, 3.58 in Q4 2025, and 2.93 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -3.15 |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 114.07 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 0.05 |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 52.24 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 4.20 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn | 0.68 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.03 |
| Mar 31, 2026 | 0.13 |
| Dec 31, 2025 | 3.58 |
| Sep 30, 2025 | -2.93 |
| Jun 30, 2025 | 5,549.82 Bn |
| Mar 31, 2025 | 5.99 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | -1.60 |
| Mar 31, 2024 | -10.34 |
| Oct 31, 2023 | -6.07 |
| Jul 31, 2023 | -4.89 |
| Apr 30, 2023 | -8.79 |
| Jan 31, 2023 | -6.50 |
| Jan 31, 2022 | -4.24 |
| Jul 31, 2021 | -14.65 |
| Apr 30, 2021 | 17.13 |
| Jan 31, 2021 | 115.76 |
| Oct 31, 2020 | -0.20 |
| Jul 31, 2020 | 7.18 |
| Apr 30, 2020 | 8.41 |